Investing 22 February 2026 - 24 February 2026

Freeport-McMoRan shares rose 1.9% to $65.55 in after-hours trading Monday, with about 15.6 million shares changing hands. Copper prices slipped 0.4% as LME warehouse stocks hit their highest since March 2025, while gold surged nearly 2% on tariff uncertainty. U.S. producer price data is due Feb. 27, and the February jobs report is set for March 6.

Sprott Inc shares rose 1.2% to $145.65 in premarket trading Monday, after a 10% surge Friday and a new 52-week high. The investment manager reported Q4 net income of $28.7 million and assets under management rising to $70.1 billion by Feb. 13. Gold climbed over 1% to a three-week high after a U.S. Supreme Court tariff ruling. Sprott’s board declared a US$0.40 dividend payable March 17.

Fortuna Mining shares rose 1.5% to $12.43 in premarket trading Monday, extending Friday’s 12.3% gain as gold hit a three-week high after the U.S. Supreme Court struck down Trump-era tariffs. The company reported record quarterly free cash flow of $132.3 million and a 73% increase in indicated gold resources at its Senegal project. Lindero mine maintenance is set for late March.

Transocean shares were flat in premarket trading Monday after closing Friday up 2.5% at $6.52. The company’s contract backlog rose to about $6.1 billion after a fleet update, with several new contracts above $400,000 per day. Investors are watching 2026 guidance and a proposed $5.8 billion all-stock deal with Valaris. Barclays downgraded the stock last week, citing ongoing risks.

GSK bought back 467,000 shares on Feb. 20 at an average price of 2,223.53 pence each under its ongoing £2 billion buyback plan. The stock closed Friday at 2,213.00 pence, down 0.58%. U.S.-listed ADRs ended at $59.52, down 2.19%. Investors await GSK’s next quarterly results on April 29.

Wesfarmers shares closed down 1.7% at A$82.58 on Monday ahead of trading ex-dividend on Feb. 24 for a A$1.02 interim payout. The S&P/ASX 200 index fell 0.61%, with losses led by tech, healthcare, and real estate. The dividend record date is Feb. 25, with payment set for March 31.

CSL Ltd shares fell 3.8% to A$147.38 on Monday, touching a 52-week low amid broad weakness in healthcare stocks. The drop followed recent profit warnings and a CEO exit, with little new company news beyond buyback filings. The S&P/ASX 200 closed down 0.61%. CSL’s buyback has reached A$654 million out of a planned US$750 million.

Corning shares jumped 7.3% to close at $139.51 Friday after UBS raised its price target to $160 and reiterated a buy rating. The stock touched a record $140.27 during the session. Investors await management’s appearances at technology conferences on Feb. 27 and March 3 for further demand signals.

Adobe shares closed down 0.23% at $258.61 Friday, falling about 2% for the week and 26% year-to-date. The broader U.S. market rose after the Supreme Court struck down Trump’s global tariffs, though Trump announced a new 10% tariff for 150 days. Investors remain cautious on software stocks ahead of earnings from Workday, Salesforce, and Nvidia next week. Adobe’s next earnings report is expected around March 12.

Eli Lilly shares fell 1.34% to $1,009.52 Friday, underperforming the S&P 500’s 0.69% gain. Investors are focused on obesity-drug pricing, supply signals, and an expected FDA decision on Lilly’s oral weight-loss pill in April. Rival Novo Nordisk’s new pill saw over 26,000 U.S. prescriptions in its second week. Lilly’s CFO is set to speak at a March 2 conference.

Deere & Co. closed at a record $662.49 on Friday, up 0.07%, after raising its 2026 net income forecast to $4.5–$5.0 billion. First-quarter net income fell to $656 million, while sales rose 13% to $9.61 billion. The stock surged 11.6% Thursday after earnings. Tariffs and farm income trends remain key factors as markets reopen Monday.